2005
DOI: 10.1016/j.ophtha.2005.01.036
|View full text |Cite
|
Sign up to set email alerts
|

Poor Prognosis of Visual Outcome after Visual Loss from Giant Cell Arteritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
127
0
5

Year Published

2008
2008
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 180 publications
(134 citation statements)
references
References 39 publications
2
127
0
5
Order By: Relevance
“…100,104 Patients with visual symptoms related to GCA generally are admitted to the hospital for intravenous glucocorticoid therapy, followed by oral therapy, although the likelihood of permanent visual deficits remains high, even among those aggressively treated. 105,106 Patients with severe symptoms related to aortitis such as acute aortic insufficiency or coronary artery involvement should similarly be treated in hospital with initial intravenous therapy. Several studies have investigated potential steroid-sparing regimens for both GCA and Takayasu arteritis because of the potential need for long-term immunosuppressive therapy.…”
Section: Gornik and Creagermentioning
confidence: 99%
“…100,104 Patients with visual symptoms related to GCA generally are admitted to the hospital for intravenous glucocorticoid therapy, followed by oral therapy, although the likelihood of permanent visual deficits remains high, even among those aggressively treated. 105,106 Patients with severe symptoms related to aortitis such as acute aortic insufficiency or coronary artery involvement should similarly be treated in hospital with initial intravenous therapy. Several studies have investigated potential steroid-sparing regimens for both GCA and Takayasu arteritis because of the potential need for long-term immunosuppressive therapy.…”
Section: Gornik and Creagermentioning
confidence: 99%
“…Several cases of Charles Bonnet syndrome have been reported (43,44). Visual manifestations usually present early in the disease course, and are rarely seen after 2-3 years of disease (25,45,46,47). In one study (25) visual impairment occurred at onset in only 2.7% as opposed to 17.9% at the time of diagnosis.…”
Section: Ophthalmologic Manifestationsmentioning
confidence: 95%
“…In rare cases, transient visual disturbances preceding permanent visual loss may alternate between the two eyes (42). The risk of developing visual disturbances has been associated with low disease activity (37,58,59), high disease activity (37,45,60), anemia (61), older age (37,38), disc swelling (37), and a history of hypertension (62). In some studies, the best predictors for the development of severe cranial ischemic events included the absence of high CRP and ESR levels at diagnosis, absence of systemic manifestations such as fever and weight loss, and a past history of ischemic heart disease (58,62).…”
Section: Ophthalmologic Manifestationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients with visual loss at presentation are unlikely to recover vision [ 11 ]. This tends to occur early, before or within the fi rst week of treatment with steroids [ 5•• , 11 , 12 ].…”
Section: Risk Factors For Neuroophthalmic Complicationsmentioning
confidence: 99%